findmyKOL

Shanika Samarasinghe, MD

Basic profile

Loyola University Medical Center

ORCIDNone on fileNPI
RegionMaywood, IL · MidwestSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Shanika Samarasinghe is an Endocrinology/Metabolic physician affiliated with Loyola University Medical Center. OpenAlex indexes 21 publications with 451 citations (h-index 6).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
21publications

Distinct works indexed by OpenAlex.

451citations

Total citations across indexed works.

6h-index

Hirsch index, productivity × impact (OpenAlex).

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

2160 S 1st Ave
Fahey Bldg 137
Maywood, IL 601533328

Telephone

708-216-9000

Registry record last updated 26 Sept 2012.

View the NPPES registry record

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    56.8%
    Insulin Analog16.7%
    Lantus Solostar37%Humalog Kwikpen U-10015%Basaglar Kwikpen U-10010%Novolog Flexpen9%Tresiba Flextouch U-1004%Fiasp Flextouch4%Insulin Lispro Kwikpen U-1004%Humalog3%Lantus3%Humalog Kwikpen U-2003%Insulin Aspart Flexpen2%Novolog2%Soliqua 100-332%Admelog Solostar2%
    Part D<11 patients
    Biguanide (metformin)12.7%
    Metformin Hcl Er55%Metformin Hcl45%
    Part D94 patients

    + 10 more classes in this area

  • Hormonal (systemic)

    23.3%
    l-Thyroxine19.8%
    Levothyroxine Sodium73%Synthroid19%Unithroid6%Levoxyl2%Tirosint2%
    Part D<11 patients
    Thyroid Hormone Synthesis Inhibitor2.1%
    Methimazole100%
    Part D29 patients

    + 3 more classes in this area

  • Cardiovascular

    15.3%
    Statin8.1%
    Atorvastatin Calcium67%Rosuvastatin Calcium18%Pravastatin Sodium10%Simvastatin5%
    Part D<11 patients
    ACE inhibitor2.9%
    Lisinopril100%
    Part D41 patients

    + 6 more classes in this area

Where care is delivered (Part B)73.6% facility · 26.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”